Abstract
Primary breast lymphoma is a rare type of non-Hodgkin lymphoma and usually affects women, although a few cases have been reported in men. Chemotherapy and radiation therapy, or a combination of both, are frequently administered for treatment of primary breast lymphoma, as local control by surgical resection is poor. No standard therapy has been established, and the optimal radiation dose and irradiation field for male patients are unknown. The present report describes a 75-year-old man with bilateral cirrhosis-induced gynecomastia who was diagnosed with primary breast lymphoma; specifically, diffuse large B-cell lymphoma. Because of his hepatic dysfunction, he was treated with radiation therapy alone. Radiation therapy was followed by eight cycles of rituximab monotherapy. Clinical response was good, with no signs of relapse. Clinicians may benefit from knowledge regarding effective treatment of primary breast lymphoma in male patients, which has been rarely reported owing to the low incidence of this condition. The outcome in the present case may help to establish effective treatment guidelines in similar cases.
Similar content being viewed by others
References
Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer. 1972;29:252–60.
Wiseman C, Liao KT. Primary lymphoma of the breast. Cancer. 1972;29:1705–12.
Radkani P, Joshi D, Paramo JC, Mesko TW. Primary breast lymphoma: 30 years of experience with diagnosis and treatment at a single medical center. JAMA Surg. 2014;149:91–3.
Ryan G, Martinelli G, Kuper-Hommel M, Tsang R, Pruneri G, Yuen K, et al. International Extranodal Lymphoma Study Group. Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group. Ann Oncol. 2008;19:233–41.
Hugh JC, Jackson FI, Hanson J, Poppema S. Primary breast lymphoma. An immunohistologic study of 20 new cases. Cancer. 1990;66:2602–11.
Guo HY, Zhao XM, Li J, Hu XC. Primary non-Hodgkin’s lymphoma of the breast: eight-year follow-up experience. Int J Hematol. 2008;87:491–7.
Sai K, Miyata G, Nakano T, Sato Y, Sano Y, Tomita Y. A case report of malignant lymphoma originating from the male breast. Med J Iwate Prefect Hosp. 1985;25:125–7.
Yamamoto A, Fujii T, Matsusaka T, Kume K, Fujinaga Y, Teraoka H, et al. A case of malignant lymphoma just near the breast. Matsuyama R C Hosp J Med. 1986;11:111–5.
Murakami S, Ishiga N, Sho T, Ishihara K, Sakai K, Iwado S, et al. A case report of malignant lymphoma originating from bilateral male breast. Jpn J Breast Cancer. 1993;8:424–7.
Okada Y, Fujioka K, Kato K, Tomono H, Fujimoto K, Mizuno K, et al. A case of primary malignant lymphoma of the male breast. J Jpn Surg Assoc. 1995;56:953–6.
Murata T, Kuroda H, Nakahama T, Goshima H, Shiraishi T, Yatani R. Primary non-Hodgkin malignant lymphoma of the male breast. Jpn J Clin Oncol. 1996;26:243–7.
Hinoshita E, Tashiro H, Takahashi II, Onohara T, Nishizaki T, Matsusaka T, et al. Primary non-Hodgkin’s lymphoma of the breast: a report of two cases. Breast Cancer. 1998;25:309–12.
Sashiyama H, Abe Y, Miyazawa Y, Nagashima T, Hasegawa M, Okuyama K, et al. Primary non-Hodgkin’s lymphoma of the male breast: a case report. Breast Cancer. 1999;25:55–8.
Mpallas G, Simatos G, Tasidou A, Patra E, Galateros G, Lakiotis G, et al. Primary breast lymphoma in a male patient. Breast. 2004;13:436–8.
Rathod J, Taori K, Disawal A, Gour P, Dhakate S, Mone R, et al. A rare case of male primary breast lymphoma. J Breast Cancer. 2011;14:333–6.
Mahmood S, Sabih Z, Sabih D. Lymphoma presenting as gynaecomastia. Biomed Imaging Interv J. 2011;7:e10.
Rastogi M, Revannasiddaiah S, Seam RK, Gupta MK, Gupta M. Extranodal lymphoma masquerading as carcinoma of the breast in an HIV-positive male patient. BMJ Case Rep. 2012;23:2012.
Mukhtar R, Mateen A, Rakha A, Khattak R, Maqsood F. Breast lymphoma presenting as gynecomastia in male patient. Breast J. 2013;19:439–40.
Glass AR. Gynecomastia. Endocrinol Metab Clin North Am. 1994;23:825–37.
Aozasa K, Ohsawa M, Saeki K, Horiuchi K, Kawano K, Taguchi T. Malignant lymphoma of the breast. Immunologic type and association with lymphocytic mastopathy. Am J Clin Pathol. 1992;97:699–704.
Yakimchuk K, Jondal M, Okret S. Estrogen receptor α and β in the normal immune system and in lymphoid malignancies. Mol Cell Endocrinol. 2013;15(375):121–9.
Yakimchuk K, Iravani M, Hasni MS, Rhönnstad P, Nilsson S, Jondal M, et al. Effect of ligand-activated estrogen receptor β on lymphoma growth in vitro and in vivo. Leukemia. 2011;25:1103–10.
Teras LR, Patel AV, Hildebrand JS, Gapstur SM. Postmenopausal unopposed estrogen and estrogen plus progestin use and risk of non-Hodgkin lymphoma in the American Cancer Society Cancer Prevention Study-II Cohort. Leuk Lymphoma. 2013;54:720–5.
Sinclair M, Gow P, Angus PW, Hoermann R, Handelsman DJ, Wittert G, et al. High circulating estrone and low testosterone correlate with adverse clinical outcomes in men with advanced liver disease. Liver Int. 2016. doi: 10.1111/liv.13122.
Talaber G, Yakimchuk K, Guan J, Inzunza J, Okret S. Inhibition of estrogen biosynthesis enhances lymphoma growth in mice. Oncotarget. 2016. doi:10.18632/oncotarget.7843.
Lin JJ, Farha GJ, Taylor RJ. Pseudolymphoma of the breast. I. In a study of 8,654 consecutive tylectomies and mastectomies. Cancer. 1980;45:973–8.
Brogi E, Harris NL. Lymphomas of the breast: pathology and clinical behavior. Semin Oncol. 1999;26:357–64.
Hosein PJ, Maragulia JC, Salzberg MP, Press OW, Habermann TM, Vose JM, et al. A multicentre study of primary breast diffuse large B-cell lymphoma in the rituximab era. Br J Haematol. 2014;165:358–63.
Liang X, Jones A, Giller RH, Swisshelm K, McGavran L, Meltesen L, et al. Primary high-grade B-cell lymphoma of the breast with concurrent IGH-BCL2 and MYC-IGL translocations in an adolescent patient. Pediatr Dev Pathol. 2011;14:402–6.
Kuper-Hommel MJ, Schreuder MI, Gemmink AH, van Krieken JH. T(14;18)(q32;q21) involving MALT1 and IGH genes occurs in extranodal diffuse large B-cell lymphomas of the breast and testis. Mod Pathol. 2013;26:421–7.
Bakheet SM, Bakheet R, Ezzat A, Tulbah A, Durakovic A, Hussain S. F-18 FDG positron emission tomography in primary breast non-Hodgkin’s lymphoma. Clin Nucl Med. 2001;26:299–301.
Nihashi T, Hayasaka K, Itou T, Ito K, Kato R, Okae T, et al. Findings of fluorine-18-FDG PET in extranodal origin lymphoma–in three cases of diffuse large B cell type lymphoma. Ann Nucl Med. 2006;20:689–93.
Jeanneret-Sozzi W, Taghian A, Epelbaum R, Poortmans P, Zwahlen D, Amsler B, et al. Primary breast lymphoma: patient profile, outcome and prognostic factors. A multicentre Rare Cancer Network study. BMC Cancer. 2008;8:86.
Avilés A, Delgado S, Nambo MJ, Neri N, Murillo E, Cleto S. Primary breast lymphoma: results of a controlled clinical trial. Oncology. 2005;69:256–60.
Avilés A, Castañeda C, Neri N, Cleto S, Nambo MJ. Rituximab and dose dense chemotherapy in primary breast lymphoma. Haematologica. 2007;92:1147–8.
Yahalom J, Illidge T, Specht L, Hoppe RT, Li YX, Tsang R, et al. International Lymphoma Radiation Oncology Group. Modern radiation therapy for extranodal lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys. 2015;92:11–31.
Fukuhara S, Watanabe T, Munakata W, Mori M, Maruyama D, Kim SW, et al. Bulky disease has an impact on outcomes in primary diffuse large B-cell lymphoma of the breast: a retrospective analysis at a single institution. Eur J Haematol. 2011;87:434–40.
Holte H, Leppä S, Björkholm M, Fluge O, Jyrkkiö S, Delabie J, et al. Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell/follicular grade 3 lymphoma patients: results of a phase II Nordic Lymphoma Group study. Ann Oncol. 2013;24:1385–92.
Cheah CY, Campbell BA, Seymour JF. Primary breast lymphoma. Cancer Treat Rev. 2014;40:900–8.
Turtle CJ. Chimeric antigen receptor modified T cell therapy for B cell malignancies. Int J Hematol. 2014;99:132–40.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
About this article
Cite this article
Ishibashi, N., Hata, M., Mochizuki, T. et al. Radiation therapy for primary breast lymphoma in male gynecomastia: a rare case report and review of the literature. Int J Hematol 104, 519–524 (2016). https://doi.org/10.1007/s12185-016-2026-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12185-016-2026-y